Treatment of scrapie pathogen 263K with tetracycline partially abolishes protease-resistant activity in vitro and reduces infectivity in vivo.
Yanjun Guo(National Institute for Viral Disease Control and Prevention), Xiao‐Ping Dong(Chinese Academy of Sciences), Hailan Yao(Capital Institute of Pediatrics), Jun Han(Union Hospital), Jin Zhang(ZheJiang Academy of Agricultural Sciences), Wei-Qin Zhao, Dexin Wang(Shanghai University of Traditional Chinese Medicine), Xiao‐Fan Wang(Shanghai University), Jian-Mei Gao(National Institute for Viral Disease Control and Prevention), Baoyun Zhang(National Institute for Viral Disease Control and Prevention)
PubMed
June 1, 2007
Cited by 6
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Signaling cross-talk between TGF-β/BMP and other pathways
|Cell Research|2008|1k
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
|Clinical Microbiology and Infection|2020|549